In A549 lung cancer cells, sestrin 2 knockdown decreased the mRNA expression of ATP-binding cassette transporter ABCG and ABCA2 (drug resistance marker genes) and increased sensitivity to doxorubicin [44]. Here, SESN2 is linked to lung carcinoma.